Evidence map›Paper›PMID 40052086›Full record

ArticleStatistics innovation2024

TCR-NP: a novel approach to prioritize T-cell Receptor repertoire network properties.

Shilpika Banerjee, Phi Le, Hai Yang, Li Zhang, Tao He

Abstract read
In one paragraph

Article in Statistics innovation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shilpika BanerjeeDepartment of Mathematics, San Francisco State University, San Francisco, CA 94132, USA.
Phi LeDepartment of Medicine, University of California San Francisco, San Francisco, CA 94143 USA.
Hai YangHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94143, USA.
Li ZhangDepartment of Medicine, University of California San Francisco, San Francisco, CA 94143 USA.
Tao HeDepartment of Mathematics, San Francisco State University, San Francisco, CA 94132, USA.

Funding

Investigation of the landscape of immunosequencing and its clinical relevance through novel immunoinformatic approachesR01LM013763 · NLM · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ZHANG, LI · 2022 to 2025
$1.4M
Computational approaches to unravel immune receptor sequencing for cancer immunotherapyR21CA264381 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ZHANG, LI · 2021 to 2022
$384k
NCI NIH HHS R21 CA264381NLM NIH HHS R01 LM013763
6 · The paper itself

Abstract

T-cell Receptors (TCRs) play a pivotal role in antigen recognition and binding, and their sequence similarity significantly impacts the breadth of antigen recognition. Network analysis is employed to explore TCR sequence similarity and investigate the architecture of the TCR repertoire. Network properties hence could be utilized to quantify the structure of the TCR network. However, the heterogeneous nature of TCR network properties poses challenges in performing statistical learning across subjects directly, particularly when assessing their relationship with disease states, clinical outcomes, or patient characteristics. To overcome this challenge, a powerful method is developed, TCR-NP (TCR Network properties Prioritization), that aggregates the raw heterogeneous network properties and conducts grouped feature selection using a pseudo-variables-assisted penalized group Lasso model. Unlike the traditional parameter-tuning using cross-validation, a novel tuning strategy is introduced by incorporating permutation and pseudo-variables to improve the selection performance. The effectiveness of the proposed method is demonstrated through comprehensive evaluation, including simulation studies and real data analysis. By comparing the performance of the different approaches, the advantages of the proposed methodology in capturing the underlying relationships between TCR network properties and clinical outcomes or patient characteristics are highlighted.

Identifiers

PMID40052086
PMCPMC11884733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.